V. LAY SUMMARY OF POINTS TO CONSIDER 
Ms. Areen, Dr. Mahoney, and Dr. Rich will work with Ms. Withe rby to prepare a 
"lay summary" for the Points to Consider in the Design and Submission of Human 
Scmatic-Cell Gene Therapy Protocols. Drs. Gottesman and Miller will serve as 
consultants to this subgroup. 
VI. FUTURE MEETINGS 
The Executive Secretary will schedule future meetings of the si±>ccmmittee when 
future meeting dates for the RAC have been set. Future meetings will be 
cancelled if there is little businesss for the subcommittee. 
VII. ADJOURNMENT 
The meeting was adjourned at 3:30 p.m. 
[40] 
Recombinant DNA Research, Volume 1 1 
